Role of glycated hemoglobin in the prediction of future risk of T2DM

Journal of Clinical Endocrinology and Metabolism

Volumn 96, Issue 8, 2011, Pages 2596-2600

  Abdul Ghani, Muhammad A ^a   Abdul Ghani, Tamam ^a   Müller, Gabriele ^b   Bergmann, Antje ^b   Fischer, Sabine ^b   Bornstein, Stefan ^c   DeFronzo, Ralph A ^a   Schwarz, Peter ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; LIPID;

ADULT; ANTHROPOMETRIC PARAMETERS; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 79961229842     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2010-1698     Document Type: Article

References (24)

1. King H, Aubert RE, Herman WH 1998 Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21:1414-1431 (Pubitemid 28405191)
2. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM 2002 Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346:393-403 (Pubitemid 34437694)
3. DREAM (Diabetes Reduction Eduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators, Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman RR 2006 Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 368:1096-1105
4. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H,Ilanne-Parikka P, Keinänen-Kiukaanniemi S, Laakso M, Louheranta A, Rastas M, Salminen V, Uusitupa M 2001 Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 344:1343-1350 (Pubitemid 32378388)
5. Unwin N, Shaw J, Zimmet P, Alberti KGMM 2002 Impaired glucose tolerance and impaired fasting glycemia: the current status on definition and intervention. Diabet Med 19:708-723 (Pubitemid 35013848)
6. Abdul-Ghani MA, Williams K, DeFronzo R, Stern M 2006 Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose. Diabetes Care 29:1613-1618 (Pubitemid 44127589)
7. Stern MP, Williams K, Haffner SM 2002 Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Int Med 136:575-581 (Pubitemid 34407041)
8. Aekplakorn W, Bunnag P, Woodward M, Sritara P, Cheepudomwit S, Yamwong S, Yipintsoi T, Rajatanavin R 2006 A risk score for predicting incident diabetes in the Thai population. Diabetes Care 29:1872-1877 (Pubitemid 44156645)
9. Wannamethee SG, Shaper AG, Lennon L, Morris RW 2005 Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 165:2644-2650 (Pubitemid 41785063)
10. Kanaya AM, Wassel Fyr CL, de Rekeneire N, Shorr RI, Schwartz AV, Goodpaster BH, Newman AB, Harris T, Barrett-Connor E 2005 Predicting the development of diabetes in older adults: the derivation and validation of a prediction rule. Diabetes Care 28:404-408 (Pubitemid 40170947)
11. Schwarz PE, Li J, Lindstrom J, Tuomilehto J 2009 Tools for predicting the risk of type 2 diabetes in daily practice. Horm Metab Res 41:86-97
12. Lindström J, Tuomilehto J 2003 The diabetes risk score: a practicaltool to predict type 2 diabetes risk. Diabetes Care 26:725-731 (Pubitemid 36929335)
13. The International Expert Committee 2009 International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes. Diabetes Care 32:1327-1334
14. American Diabetes Association 2010 Diagnosis and classification of diabetes mellitus. Diabetes Care 33:S62-S69
15. Schwarz PE, Towers GW, Fischer S, Govindarajalu S, Schulze J, Bornstein SR, Hanefeld M, Vasseur F 2006 Hypoadiponectinemia is associated with progression toward type 2 diabetes and genetic variation in the ADIPOQ gene promoter. Diabetes Care 29:1645-1650 (Pubitemid 44127594)
16. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus 1997 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197
17. DeLong ER, DeLong DM, Clarke-Pearson DL 1988 Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44:837-845
18. Abdul-Ghani MA, Abdul-Ghani T, Ali N, Defronzo RA 2008 One hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for type 2 diabetes. Diabetes Care 31:1650-1655
19. Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M 2007 What is the best predictor of future type 2 diabetes? Diabetes Care 30:1544-1548 (Pubitemid 46871168)
20. Abdul-Ghani MA, Lyssenko V, Tuomi T, DeFronzo RA, Groop L 2009 Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study. Diabetes Care 32:281-286
21. Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS, Bainbridge KE, Fradkin JE 2010 Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988-2006. Diabetes Care 33:562-568
22. Carson AP, Reynolds K, Fonseca VA, Muntner P 2010 Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults. Diabetes Care 33:95-97
23. Edelman D, Olsen MK, Dudley TK, Harris AC, Oddone EZ 2004 Utility of hemoglobin A1c in predicting diabetes risk. J Gen Intern Med 19:1175-1180 (Pubitemid 40041381)
24. 1c in predictingprogression to diabetes in Frenchmenand women: data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 29:1619-1625